For BRCA1 mutation carriers, there is a predominant predisposition of breast and ovarian cancer, while BRCA2 mutation carriers also show a significantly higher risk of pancreatic, prostate, and other types of cancers in addition to breast and ovarian cancers198,199. Here, BRCA2 is linked to ovarian carcinoma.